CASE REPORT |
|
Year : 2017 | Volume
: 16
| Issue : 3 | Page : 145-147 |
|
Primary hyperparathyroidism in pregnancy
Meryem Rchachi1, Hanan El Ouahabi1, Saïd Boujraf2, Farida Ajdi3
1 Department of Endocrinology and Metabolism, University Hospital of Fez, Fez, Morocco 2 Department of Biophysics and Clinical MRI Methods, Faculty of Medicine and Pharmacy of Fez, Fez, Morocco 3 Department of Endocrinology and Metabolism, Faculty of Medicine and Pharmacy of Agadir, Agadir, Morocco
Correspondence Address:
Saïd Boujraf Department of Biophysics and Clinical MRI Methods, Faculty of Medicine and Pharmacy, University of Fez, BP. 1893, Km 2.200, Sidi Hrazem Road, Fez 30000 Morocco
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/aam.aam_61_16
|
|
Primary hyperparathyroidism (PHT) is a frequent and asymptomatic pathology in 80% of patients, and a parathyroidal adenoma is found in the most case. However, rare cases might occur during pregnancy; and the literature reported up to 200 cases. We report three cases of PHT that occurred during the second and last third trimesters of pregnancy stage in patients aged 26, 42 and 32-year-old. Despite diagnosis limitations, since scintigraphy is prohibited in pregnancy, the patients were managed conservatively with good prognosis for both mothers and babies.
L'hyperparathyroïdie primaire (HTP) est une maladie fréquente et asymptomatique chez 80% des patients. Un adénome parathyroïdien est retrouvé chez une grande majorité des cas. Cependant, l'apparition au cours de la grossesse est particulièrement rare et la littérature ne rapporte que 200 cas. Nous en rapportons 3 cas d'hyperparathyroïdie âgés de 26, 42 et 32 ans, survenue au cours du deuxième et troisième trimestre de la grossesse. Malgré les limites diagnostiques dues à l'interdiction de la scintigraphie au cours de la grossesse, la gestion avait été faite de façon très conservative de sorte à avoir le meilleur pronostic pour les patientes leurs fétus. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|